Sialyltransferase activity and atherosclerosis

Circulation Research

Volumn 114, Issue 6, 2014, Pages 935-937

  Sage, Andrew P ^a   Mallat, Ziad ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b INSERM   (France)

Author keywords

atherosclerosis; CC chemokine receptors; chemokines; CX3C chemokine receptors; CXC chemokine receptors; Editorials; leukocytes

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR2; CHOLESTEROL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FUCOSYLTRANSFERASE; L SELECTIN; PADGEM PROTEIN; SIALIDASE; SIALYLTRANSFERASE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTERY LESION; ATHEROGENESIS; ATHEROSCLEROSIS; BINDING SITE; BONE MARROW CELL; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; EDITORIAL; ENZYME ACTIVITY; FUCOSYLATION; GENE TARGETING; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE ACTIVATION; LEUKOCYTE ROLLING; MONOCYTE; NEUTROPHIL; NONHUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SIALYLATION; WILD TYPE;

ATHEROSCLEROSIS; CC CHEMOKINE RECEPTORS; CHEMOKINES; CX3C CHEMOKINE RECEPTORS; CXC CHEMOKINE RECEPTORS; EDITORIALS; LEUKOCYTES;

ANIMALS; ATHEROSCLEROSIS; CHEMOKINE CCL5; FEMALE; LEUKOCYTE ROLLING; MALE; MYELOID CELLS; SIALYLTRANSFERASES;

EID: 84897867825     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.114.303480     Document Type: Editorial

References (20)

1. Swirski FK, Wildgruber M, Ueno T, Figueiredo JL, Panizzi P, Iwamoto Y, Zhang E, Stone JR, Rodriguez E, Chen JW, Pittet MJ, Weissleder R, Nahrendorf M. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macro-phages in atheromata. J. Clin. Invest. 2007;117:195-205.
2. Drechsler M, Megens RT, van Zandvoort M, Weber C, Soehnlein O. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation. 2010;122:1837-1845.
3. Robbins CS, Chudnovskiy A, Rauch PJ, et al. Extramedullary hemato-poiesis generates Ly-6Chigh monocytes that infltrate atherosclerotic lesions. Circulation. 2012;125:364-374.
4. Li H, Cybulsky MI, Gimbrone MA Jr, Libby P. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb. 1993;13:197-204.
5. Weber C, Zernecke A, Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol. 2008;8:802-815.
6. Mestas J, Ley K. Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc Med. 2008;18:228-232.
7. Braunersreuther V, Zernecke A, Arnaud C, Liehn EA, Steffens S, Shagdarsuren E, Bidzhekov K, Burger F, Pelli G, Luckow B, Mach F, Weber C. Ccr5 but not Ccr1 defciency reduces development of diet-induced atherosclerosis in mice. Arterioscler Thromb Vasc Biol. 2007;27:373-379.
8. Potteaux S, Combadière C, Esposito B, Casanova S, Merval R, Ardouin P, Gao JL, Murphy PM, Tedgui A, Mallat Z. Chemokine receptor CCR1 disruption in bone marrow cells enhances atherosclerotic lesion development and infammation in mice. Mol Med. 2005;11:16-20.
9. Rozenberg I, Sluka SH, Mocharla P, Hallenberg A, Rotzius P, Borén J, Kränkel N, Landmesser U, Borsig L, Lüscher TF, Eriksson EE, Tanner FC. Deletion of L-selectin increases atherosclerosis development in ApoE-/-mice. PLoS One. 2011;6:e21675.
10. Veillard NR, Steffens S, Pelli G, Lu B, Kwak BR, Gerard C, Charo IF, Mach F. Differential infuence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo. Circulation. 2005;112:870-878.
11. Combadière C, Potteaux S, Rodero M, Simon T, Pezard A, Esposito B, Merval R, Proudfoot A, Tedgui A, Mallat Z. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocy-tosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation. 2008;117:1649-1657.
12. Sperandio M, Gleissner CA, Ley K. Glycosylation in immune cell traf-fcking. Immunol Rev. 2009;230:97-113.
13. Homeister JW, Daugherty A, Lowe JB. Alpha(1, 3)fucosyltransferases FucT-IV and FucT-VII control susceptibility to atherosclerosis in apoli-poprotein E-/-mice. Arterioscler Thromb Vasc Biol. 2004;24:1897-1903.
14. Gitlin JM, Homeister JW, Bulgrien J, Counselman J, Curtiss LK, Lowe JB, Boisvert WA. Disruption of tissue-specifc fucosyltransferase VII, an enzyme necessary for selectin ligand synthesis, suppresses atherosclerosis in mice. Am J Pathol. 2009;174:343-350.
15. Yang WH, Nussbaum C, Grewal PK, Marth JD, Sperandio M. Coordinated roles of ST3Gal-VI and ST3Gal-IV sialyltransferases in the synthesis of selectin ligands. Blood. 2012;120:1015-1026.
16. Frommhold D, Ludwig A, Bixel MG, et al. Sialyltransferase ST3Gal-IV controls CXCR2-mediated frm leukocyte arrest during infammation. J Exp Med. 2008;205:1435-1446.
17. Bannert N, Craig S, Farzan M, Sogah D, Santo NV, Choe H, Sodroski J. Sialylated O-glycans and sulfated tyrosines in the NH2-terminal domain of CC chemokine receptor 5 contribute to high affnity binding of che-mokines. J Exp Med. 2001;194:1661-1673.
18. Döring Y, Noels H, Mandel M, et al. Defciency of the sialyltransfer-ase St3Gal4 reduces Ccl5-mediated myeloid cell recruitment and arrest. Circ Res. 2014;114:976-981.
19. Abe Y, Smith CW, Katkin JP, Thurmon LM, Xu X, Mendoza LH, Ballantyne CM. Endothelial alpha 2, 6-linked sialic acid inhibits VCAM-1-dependent adhesion under fow conditions. J Immunol. 1999;163:2867-2876.
20. Gracheva EV, Samovilova NN, Golovanova NK, Il'inskaya OP, Tararak EM, Malyshev PP, Kukharchuk VV, Prokazova NV. Sialyltransferase activity of human plasma and aortic intima is enhanced in atherosclerosis. Biochim Biophys Acta. 2002;1586:123-128.